Press Releases

Friday, Aug 14, 2015
Press Releases

Adam Smith Conferences’ brand new event will assess the evolving role of Medical Affairs in Pharmaceutical companies. Medical Affairs in Russia Forum – 24 – 26 November 2015, Metropol Hotel, Moscow http://www.adamsmithconferences.com/AS2388PT Participants will discuss issues such as current organisational structures, responsibilities, and MA cross-functional collaboration with Marketing, Regulatory, Market…

Press Releases

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. ("Advanced Dosage") to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada.  Under the agreement,…

Press Releases

Genentech, a member of the Roche Group, announced positive results today from the Phase II M13-982 study of venetoclax, an investigational medicine being developed in partnership with AbbVie. The study met its primary endpoint, showing that venetoclax monotherapy resulted in a clinically meaningful reduction in the number of cancer cells…

Press Releases

CMC Biologics, a global leader in clinical and commercial development and contract manufacture of therapeutic proteins, announced today it has entered into an agreement with the PATH Malaria Vaccine Initiative (MVI) for process development and manufacture of specific monoclonal antibodies to test for their capacity to protect humans from malaria…

Thursday, Aug 13, 2015
Press Releases

Alfa Laval Rotary Jet Mixer effectively handles liquid and powder mixing, gas dispersion and Cleaning-in-Place (CIP) while reducing time, energy and costs. In many applications the Alfa Laval Rotary Jet Mixer provides a faster and more efficient mixing than conventional methods. It combines high blending precision with minimized mixing times…

Press Releases

Allergan plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Posaconazole Delayed-Release Tablets, 100mg. Allergan's ANDA product is a generic version of Merck's Noxafil® which is an antifungal agent indicated for prophylaxis of invasive…

Press Releases

Clovis Oncology, Inc. announced today that they have entered into a clinical trial collaboration with Genentech, a member of the Roche Group to evaluate a novel combination therapy of Genentech’s investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) and rociletinib for the treatment of advanced EGFR-mutant non-small cell lung cancer (NSCLC). Rociletinib…

Press Releases

Janssen Biotech, Inc. (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies. The agreement was facilitated by Johnson & Johnson Innovation, London. Under terms of the…

Press Releases

Relypsa, Inc., a biopharmaceutical company, and Vifor Fresenius Medical Care Renal Pharma Ltd. (VFMCRP), a common company of Galenica and Fresenius Medical Care, today announced they have entered into an exclusive partnership to commercialize Patiromer for Oral Suspension (Patiromer FOS), Relypsa's investigational medicine for the treatment of hyperkalemia. Under the…

Press Releases

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on discovering and developing treatments for serious and life-threatening diseases, today announced the completion of its Series A financing. The $90 million round was led by Martin Shkreli, Founder & Chief Executive Officer. One of the largest Series A rounds in biotech…